Norges Bank Makes New Investment in Huron Consulting Group Inc. (NASDAQ:HURN)

Norges Bank acquired a new stake in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 59,773 shares of the business services provider's stock, valued at approximately $7,427,000. Norges Bank owned 0.34% of Huron Consulting Group as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Dakota Wealth Management lifted its holdings in Huron Consulting Group by 4.0% during the fourth quarter. Dakota Wealth Management now owns 2,250 shares of the business services provider's stock worth $280,000 after acquiring an additional 87 shares in the last quarter. Andina Capital Management LLC grew its position in shares of Huron Consulting Group by 3.4% during the 4th quarter. Andina Capital Management LLC now owns 3,296 shares of the business services provider's stock worth $410,000 after purchasing an additional 107 shares in the last quarter. Hillsdale Investment Management Inc. increased its stake in Huron Consulting Group by 0.5% during the 4th quarter. Hillsdale Investment Management Inc. now owns 34,060 shares of the business services provider's stock worth $4,232,000 after acquiring an additional 160 shares during the period. Keybank National Association OH boosted its position in shares of Huron Consulting Group by 4.2% during the 4th quarter. Keybank National Association OH now owns 4,120 shares of the business services provider's stock worth $512,000 after acquiring an additional 167 shares in the last quarter. Finally, Heck Capital Advisors LLC acquired a new position in Huron Consulting Group during the fourth quarter valued at approximately $33,000. Institutional investors own 93.90% of the company's stock.

Insider Buying and Selling

In other news, Director H Eugene Lockhart sold 12,500 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $150.00, for a total transaction of $1,875,000.00. Following the transaction, the director now owns 12,172 shares in the company, valued at approximately $1,825,800. This trade represents a 50.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director John Mccartney sold 500 shares of the business's stock in a transaction on Tuesday, April 1st. The stock was sold at an average price of $142.67, for a total value of $71,335.00. Following the completion of the transaction, the director now directly owns 52,121 shares of the company's stock, valued at approximately $7,436,103.07. The trade was a 0.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 78,781 shares of company stock valued at $11,484,452. Corporate insiders own 2.02% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Wedbush raised their price target on shares of Huron Consulting Group from $150.00 to $165.00 and gave the company an "outperform" rating in a research note on Wednesday, March 26th. Barrington Research reissued an "outperform" rating and set a $167.00 target price on shares of Huron Consulting Group in a report on Thursday, March 27th. Truist Financial boosted their price target on shares of Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. Benchmark reissued a "buy" rating and issued a $165.00 price target on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Finally, William Blair reiterated an "outperform" rating on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $169.25.

Huron Consulting Group Stock Performance

Shares of HURN stock traded up $1.12 during mid-day trading on Monday, reaching $144.39. 8,354 shares of the company's stock traded hands, compared to its average volume of 140,714. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. The firm has a market capitalization of $2.59 billion, a PE ratio of 31.40 and a beta of 0.37. Huron Consulting Group Inc. has a 12 month low of $84.26 and a 12 month high of $153.85. The firm has a 50 day moving average price of $139.67 and a two-hundred day moving average price of $126.58.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last released its earnings results on Tuesday, February 25th. The business services provider reported $1.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.52 by $0.38. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The company had revenue of $399.31 million during the quarter, compared to analyst estimates of $380.62 million. On average, research analysts forecast that Huron Consulting Group Inc. will post 6.1 EPS for the current year.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.